We provide quantitative data, from 50,424 surveys at 36,966 geocoded locations, that covers 115 years of malaria history in sub-Saharan Africa; inferring from these data to future trends, we would expect continued reductions in malaria transmission, punctuated with resurgences.
control malaria focused on areas of European economic influence, primarily by targeting vector larvae or through mass quinine administration campaigns targeting the parasite itself 6 ; we did not observe declines in transmission associated with these efforts.
We observed two precipitous declines in infection prevalence, both of which followed rises in prevalence. The period from 1960 to 1984 was characterized by a slow decline in malaria prevalence across Africa (Fig. 2) . Counter-intuitively, this coincided with a cessation of malaria elimination ambitions across much of sub-Saharan Africa 8 , with an emerging resistance among mosquitoes to organochloride insecticides 9 and with a period in which malaria was integrated into broader health agendas that focused on the presumptive treatment of fevers with choroquine, a cheap, widely available and efficacious drug. This interval also included drought periods across much of the Sahel 10 ( Fig. 2) , which rendered some areas unsuitable for malaria transmission 11 . Therefore, although several interventions may have influenced the observed trends, no single factor appears sufficient to account for them all.
Between 1985 and 2004, however, median malaria prevalence rose to levels similar to those witnessed fifty years earlier, before the introduction of DDT (Fig. 2) . This period also saw a rapid expansion of chloroquine resistance across Africa 12 , climate anomalies connected with changes in Pacific Ocean sea surface temperatures 10 ( Fig. 2) , and the failure of many national health agencies to prioritize the growing malaria epidemic because of a lack of international donor assistance 13 . Despite impressive gains in the coverage of effective interventions since 2005, the rate of reduction of malaria prevalence has slowed during the interval 2010-2015 (Fig. 2) . Continued challenges to malaria control include difficulties in ensuring access to artemisinin-based combination therapies, the threat of drug resistance, rapidly emerging insecticide resistance and inadequate funding plans for replacing long-lasting insecticide-treated nets 14 .
There has been an overall decline in malaria transmission intensity over the past 115 years. Independent abiotic factors related to economic growth may have contributed to this overall decline, but the constant growth in sub-Saharan African GDP, urbanization and/or female education charted by the World Bank (World Development Indicators, (Fig. 2) ; the linear phenomena of global warming cannot explain the precipitous declines in malaria prevalence witnessed after 2004. The interplay among malaria, climate, effective or failing intervention, human settlement and development is inevitably complex. Our analysis highlights the fact that a focus on simple, single factors fails to adequately explain the cycles of parasite prevalence.
The reduction in malaria transmission intensity has not occurred equally between countries or within countries (Fig. 1) , with more substantive declines and 'shrinking of the map' occurring at the margins of the historical range of P. falciparum transmission than in the heartland of Africa's most efficient vector species, Anopheles gambiae sensu stricto and Anopheles coluzzii. This heartland forms a densely populated belt from West Africa through Central Africa toward Mozambique, and represents the most severely impacted area of the contemporary malaria-endemic world: it was ignored after 1960 17, 18 and risks being ignored today 19 . Our previous and current armoury of interventions has not eliminated malaria in this part of the world, and there is little indication that it will do so in the foreseeable future.
Although caution is required in predicting a complex future, if past trends remain consistent we would expect further reductions in the range and intensity of malaria transmission in Africa, punctuated with resurgences. We show the implausibility of simple explanations for temporal trends over the past 115 years, and therefore caution against using similar explanations for the trend of the past 15 years (for example, in ascribing this trend to human intervention alone). The unique malaria endemicity that prevails in Africa cannot be ignored in global efforts to eliminate P. falciparum, nor should we wait for future rises in malaria prevalence to re-galvanize interest in a parasite that remains entrenched across large parts of the continent.
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No statistical methods were used to predetermine sample size. Data Assembly. Over the past 21 years, we have sourced unpublished and published materials related to community-based malaria infection prevalence at European, United Nations and African national libraries, archives and ministry of health repositories. We undertook standard electronic data searches of peerreviewed publications, and contacted malaria scientists, regional health research institutes, and government and non-government agencies involved in the delivery and monitoring of malaria interventions (Supplementary Information 1.3, 1.4) . The minimum data requirements for the survey included the date and location, age range and numbers for participants examined, infection prevalence by species, and parasite detection method. A total of 50,424 parasite prevalence surveys were included 4 (Extended Data Figs 1, 2, Supplementary Information 1.5) . Spatial limits and resolution of malaria predictions. We excluded previously endemic North African countries (Morocco, Algeria, Tunisia, Libya and Egypt), off-shore islands and countries where malaria has not been described (Western Sahara and Lesotho). Guided by the United Nations' GAUL project (http://www. fao.org/geonetwork/srv/en/metadata.show?id= 12691), we used current national and sub-national first-level administrative boundary units, with adaptations for the margins of natural P. falciparum risk and for disputed boundaries; we also dissolved the boundaries of small urban municipalities and ensured contiguous shapes between sub-national units. Rwanda, Burundi, Djibouti, Swaziland and The Gambia were treated as single polygons (Supplementary Information 2.1, 2.2; see Source Data of Fig. 1 ). The natural spatial limits of P. falciparum risk were derived from expert opinion, national maps and biological constraints (Supplementary Information 2.2; see Source Data of Fig. 1 ). The selection of 520 spatial polygons at the natural range of P. falciparum transmission is shown in Extended Data Fig. 3 . Changing limits were mapped using data from national reports of malaria incidence from the 1960s onward ( Supplementary Information 2. 3; see Source Data of Fig. 1) . Statistical methods. We used a Bayesian hierarchical binomial model that simultaneously estimates stable spatial and temporal structured patterns and departures from these stable components 5 . The input data were as follows: observed number of children aged 2-10 years with P. falciparum (PfPR it ) and total number of tested children aged 2-10 years (n it ) for subnational region (i, from 1 to 520) and time periods (t = 1-16, corresponding to [1930] [1931] [1932] [1933] [1934] [1935] [1936] [1937] [1938] [1939] [1940] [1941] [1942] [1943] [1944] Fig. 1 ). Gelman-Rubin statistics were used to assess model convergence (Extended Data Fig. 4) . Output was validated using observed versus fitted PfPR 2-10 from the full model (Extended Data Fig. 5) . Ethics statement. As the secondary use of aggregate survey data, our research centre considered the work to be non-human research for which individual informed consent was not applicable. 
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